Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lethagen

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
European Journal of Anaesthesiology. Supplement|March 1, 1997
The UK guidelines for the use of desmopressin in patients with von Willebrand's disease. Von Willebrand Working Party of the United Kingdom Haemophilia Centre Director's OrganizationS Lethagen, P Flordal, H Van Aken, et al.
Lakartidningen|July 8, 1992
[New preparations for coagulation disorders]L Tengborn, L Stigendal, E Berntorp, et al.
Journal of Pharmaceutical Sciences|June 1, 1989
Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressinA S Harris, M Ohlin, E Svensson, et al.
Journal of Pharmaceutical Sciences|May 1, 1988
Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressinA S Harris, E Svensson, Z G Wagner, et al.
Blood|May 9, 2001
Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndromeD Karpman, D Papadopoulou, K Nilsson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in SwedenK Steen Carlsson, S Höjgård, S Lethagen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
The impact of hepatitis C antibody screening of source plasma donors on hepatitis C virus RNA in factor VIII concentratesE Berntorp, S Lethagen, E Nordenfelt, et al.
Thrombosis and Haemostasis|May 6, 1998
Ins405AsnPro mutation in the von Willebrand factor propeptide in recessive type 2A (IIC) von Willebrand's diseaseL Holmberg, D Karpman, C Isaksson, et al.
European Journal of Anaesthesiology. Supplement|March 1, 1997
Guidelines for the diagnosis and management of von Willebrand's diseaseM Cattaneo, B J Hunt, H Van Aken, et al.
Thrombosis Research|July 19, 2000
Correlation between different intensities of anti-vitamin K treatment and coagulation parametersA Jerkeman, J Astermark, U Hedner, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
European Journal of Anaesthesiology. Supplement|March 1, 1997
The UK guidelines for the use of desmopressin in patients with von Willebrand's disease. Von Willebrand Working Party of the United Kingdom Haemophilia Centre Director's OrganizationS Lethagen, P Flordal, H Van Aken, et al.
Lakartidningen|July 8, 1992
[New preparations for coagulation disorders]L Tengborn, L Stigendal, E Berntorp, et al.
Journal of Pharmaceutical Sciences|June 1, 1989
Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressinA S Harris, M Ohlin, E Svensson, et al.
Journal of Pharmaceutical Sciences|May 1, 1988
Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressinA S Harris, E Svensson, Z G Wagner, et al.
Blood|May 9, 2001
Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndromeD Karpman, D Papadopoulou, K Nilsson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in SwedenK Steen Carlsson, S Höjgård, S Lethagen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
The impact of hepatitis C antibody screening of source plasma donors on hepatitis C virus RNA in factor VIII concentratesE Berntorp, S Lethagen, E Nordenfelt, et al.
Thrombosis and Haemostasis|May 6, 1998
Ins405AsnPro mutation in the von Willebrand factor propeptide in recessive type 2A (IIC) von Willebrand's diseaseL Holmberg, D Karpman, C Isaksson, et al.
European Journal of Anaesthesiology. Supplement|March 1, 1997
Guidelines for the diagnosis and management of von Willebrand's diseaseM Cattaneo, B J Hunt, H Van Aken, et al.
Thrombosis Research|July 19, 2000
Correlation between different intensities of anti-vitamin K treatment and coagulation parametersA Jerkeman, J Astermark, U Hedner, et al.
Pageof 10